In the realm of cancer treatments, your skin often bears the brunt of damage. The facial skin, in particular, succumbs to dryness and weakness, exacerbated by the impacts of chemotherapy and targeted therapy. When compromised, the skin tightens, and redness may manifest. It is imperative to employ a quality moisturizer for daily use, right from the initiation of your treatments. 

Our enriching moisturizer takes on the challenges of dry skin, redness, and irritation with heightened efficacy, all while maintaining a delicate touch. Its fluid consistency allows for effortless application across your face and neck. Lightweight and boasting a non-greasy finish, it effortlessly penetrates, leaving your skin remarkably soft and serving as an excellent foundation for your makeup. 

In a commitment to a formula that prioritizes your well-being and is even more universally tolerated by all skin types, we’ve made subtle adjustments to the fragrance of our Face Cream. Retaining its signature light and fresh aroma, it now stands even milder, catering to those with heightened sensitivity and those impacted by treatments, without triggering any potential nausea during chemotherapy. Rest assured, the active ingredients of our Face Cream remain unchanged, ensuring consistent effectiveness in caring for the driest and most sensitive skin types. 

• Rapid penetration observed by 91% of volunteers* 
• Non-greasy finish experienced by 91% of volunteers* 
• Skin nourishment reported by 96% of volunteers* 
• Effective against dry facial skin, according to 96% of volunteers* 
• Alleviates sensations of discomfort (tightness, itching) in the face for 95% of volunteers* 
• Increased facial skin hydration noted by 95% of volunteers* 
• Softer facial skin observed by 95% of volunteers* 
• Smoother facial skin reported by 95% of volunteers* 
• Improved suppleness of facial skin seen by 91% of volunteers* 
• Reduction in facial redness reported by 91% of volunteers* 
• Refreshing effect noted by 87% of volunteers 
• Facial skin protection perceived by 86% of volunteers* 

*Results from a multicenter study conducted on a similar formula involving 70 women undergoing anti-cancer treatment at the Léon Bérard Cancer Centre and Jean Mermoz Private Hospital in Lyon, France.